No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
Updated: 2026-05-29 · v2.0 · Prof. G. Pkhakadze, MD, MPH, PhDCiteEditorial
📰Read the full Picamilon evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.
3
Limited
Picamilon
Nicotinoyl-GABA
Limited EvidenceLimitedRestricted
RDA
Typical 50–100 mg
Target
N/A
Upper limit
No UL in supplement context
Products
18
Dosage by population group — reference
⚠ See overview for critical safety [1]
ℹ️ Not obtained from food. Not applicable — this is not obtained from food in meaningful amounts; supplementation is the practical route.
🔬 Lab interpreter
ℹ️ No validated blood test. There is no established laboratory test to assess status or guide dosing for this ingredient. Clinical response and symptoms are the practical guide.
⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Picamilon is a SYNTHETIC Russian prescription drug (nicotinoyl-GABA) that FDA ruled is NOT a legitimate dietary supplement (2015). It was designed to deliver GABA across the BBB — an elegant pharmacological approach. Still prescription in Russia for cerebrovascular/anxiety disorders. Found illegally in some US 'nootropic' and 'focus' supplements. Patients buying picamilon products are purchasing an unapproved drug, not a supplement [1].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Avoid — synthetic drug with no pregnancy safety data [1].
👦 Pediatric: See guidance
Not recommended [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose

How to take

🍽 Timing: See overview [1].
💊 With food: See overview [1].
🚫 Avoid: See overview [1].
2 Which form?
FormBioavailabilityVeganCost
['Various forms', 'standard', 'See overview [1].']StandardCheck label
3 Common questions
Key point
Picamilon is a SYNTHETIC Russian prescription drug (nicotinoyl-GABA) that FDA ruled is NOT a legitimate dietary supplement (2015). It was designed to deliver GABA across the BBB — an elegant pharmacological approach. Still prescription in Russia for cerebrovascular/anxiety disorders. Found illegally in some US 'nootropic' and 'focus' supplements. Patients buying picamilon products are purchasing an unapproved drug, not a supplement [1].
4 Clinical evidence

Strong

See overview [1]. HIGH

Moderate

See overview [1]. MODERATE

Insufficient

See overview [1]. LOW
5 Safety, toxicity & adverse events

Absolute contraindications

✕ Not a lawful dietary ingredient (US FDA) — a synthetic GABA-niacin drug

Relative

⚠ Antihypertensives — additive blood-pressure lowering (vasodilatory)
⚠ Concurrent CNS depressants
⚠ Pregnancy and lactation — no safety data
6 Interactions

Drug interactions

Antihypertensives Major
Mechanism: Niacin component causes vasodilation — additive hypotension [1].
7 US supplement products
18
on-market products containing Picamilon (NIH DSLD)

Brands carrying Picamilon (6)

Click a brand to see its Picamilon products.
Or browse all 18 products in one list →
8 Frequently paired with
Creatine 14 sharedBeta-Alanine 14 shared
9 Cite this page
Vancouver: Pkhakadze G. Picamilon — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Aug 31]. Available from: https://supplement.ge/ingredients/picamilon/
APA 7th: Pkhakadze, G. (2026). Picamilon — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/picamilon/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: March 2027
References: 2 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Picamilon — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/picamilon/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network